WallStSmart

Newmont Goldcorp Corp (NEM)vsNovartis AG ADR (NVS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Novartis AG ADR generates 127% more annual revenue ($56.58B vs $24.97B). NEM leads profitability with a 33.9% profit margin vs 23.9%. NVS appears more attractively valued with a PEG of 2.59. NEM earns a higher WallStSmart Score of 78/100 (B+).

NEM

Strong Buy

78

out of 100

Grade: B+

Growth: 10.0Profit: 9.5Value: 4.0Quality: 8.0
Piotroski: 6/9Altman Z: 2.04

NVS

Buy

51

out of 100

Grade: C-

Growth: 3.3Profit: 9.0Value: 3.3Quality: 5.5
Piotroski: 4/9Altman Z: 1.96
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NEMSignificantly Overvalued (-81.0%)

Margin of Safety

-81.0%

Fair Value

$68.86

Current Price

$116.51

$47.65 premium

UndervaluedFair: $68.86Overvalued
NVSSignificantly Overvalued (-51.8%)

Margin of Safety

-51.8%

Fair Value

$110.12

Current Price

$146.03

$35.91 premium

UndervaluedFair: $110.12Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NEM6 strengths · Avg: 9.8/10
Profit MarginProfitability
33.9%10/10

Keeps 34 of every $100 in revenue as profit

Operating MarginProfitability
61.4%10/10

Strong operational efficiency at 61.4%

Revenue GrowthGrowth
45.8%10/10

Revenue surging 45.8% year-over-year

EPS GrowthGrowth
78.6%10/10

Earnings expanding 78.6% YoY

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Market CapQuality
$124.38B9/10

Large-cap with strong market position

NVS5 strengths · Avg: 9.4/10
Market CapQuality
$277.42B10/10

Mega-cap, among the largest globally

Return on EquityProfitability
34.9%10/10

Every $100 of equity generates 35 in profit

Operating MarginProfitability
30.5%10/10

Strong operational efficiency at 30.5%

Profit MarginProfitability
23.9%9/10

Keeps 24 of every $100 in revenue as profit

Free Cash FlowQuality
$2.87B8/10

Generating 2.9B in free cash flow

Areas to Watch

NEM1 concerns · Avg: 2.0/10
PEG RatioValuation
2.782/10

Expensive relative to growth rate

NVS4 concerns · Avg: 2.5/10
Altman Z-ScoreHealth
1.964/10

Grey zone — moderate risk

PEG RatioValuation
2.592/10

Expensive relative to growth rate

Revenue GrowthGrowth
-0.7%2/10

Revenue declined 0.7%

EPS GrowthGrowth
-9.3%2/10

Earnings declined 9.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : NEM

The strongest argument for NEM centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 33.9% and operating margin at 61.4%. Revenue growth of 45.8% demonstrates continued momentum.

Bull Case : NVS

The strongest argument for NVS centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 23.9% and operating margin at 30.5%.

Bear Case : NEM

The primary concerns for NEM are PEG Ratio.

Bear Case : NVS

The primary concerns for NVS are Altman Z-Score, PEG Ratio, Revenue Growth.

Key Dynamics to Monitor

NEM profiles as a growth stock while NVS is a declining play — different risk/reward profiles.

NVS carries more volatility with a beta of 0.49 — expect wider price swings.

NEM is growing revenue faster at 45.8% — sustainability is the question.

NEM generates stronger free cash flow (3.1B), providing more financial flexibility.

Bottom Line

NEM scores higher overall (78/100 vs 51/100), backed by strong 33.9% margins and 45.8% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Newmont Goldcorp Corp

BASIC MATERIALS · GOLD · USA

Newmont Corporation, based in Greenwood Village, Colorado, United States, is one of the largest gold mining companies in the world.

Visit Website →

Novartis AG ADR

HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA

Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.

Visit Website →

Want to dig deeper into these stocks?